ZETA|Newsroom|From Upstream to Downstream
From to ZETA
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Technical Text

From Upstream to Downstream

ZETA successfully delivered a comprehensive biopharmaceutical production system covering upstream, harvest, and downstream processes, including cultivation, extraction, and purification of therapeutic proteins. The project showcased ZETA’s expertise in digitalization, engineering, and fast-track execution, resulting in a highly flexible, GMP-compliant multiproduct facility for monoclonal antibody production.
Digital Value ChainProcess ExpertiseTechnical Text
Employee handling downstream production skid

Solutions for the biopharmaceutical process

The biotechnological production of proteins can be separated into production or upstream processes, and purification or downstream processes. Cells or microorganisms are grown and cultivated as part of the upstream process. Once the desired proteins have been produced in sufficient quantity, the product is extracted and purified in the downstream process.

The success of a highly customized complex project demonstrates ZETA’s expertise across all areas of the production process. An international biopharmaceutical company awarded ZETA responsibility for the entire production process, from upstream to downstream.

Employee handling downstream production skid

We’re just a message away.
Connect with a trusted expert.

Michael Christ
Teamleader Project Management
Portrait picture of a person wearing a white shirt and a black blazer in front of a light background.
I would like to receive regular information and electronic advertising and agree that my data may be processed and used for this purpose by all companies of the ZETA Group worldwide.
zeta.com is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. By submitting, I agree to the Terms of Use and the Privacy Policy.
>

Download technical text from upstream to downstream

ZETA delivered a flexible, GMP-compliant facility for monoclonal antibody production, integrating upstream to downstream biopharmaceutical processes. The project highlighted their strengths in digitalization, engineering, and fast-track execution.

Please complete the form to receive the requested content.

zeta.com is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. By submitting, I agree to the Terms of Use and the Privacy Policy.

Show content